Richard J. O. Barnard

Monosynaptic Restriction of Transsynaptic Tracing from Single, Genetically Targeted Neurons

Ian R. Wickersham, David C. Lyon, Richard J. O. Barnard et al. · Neuron · 2007 · 1.2K citations · Full text

Synaptic Plasticity, Developmental Biology, Health Sciences +11

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Jeffrey L. Lennox, Edwin DeJesus, Adriano Lazzarin et al. · The Lancet · 2009 · 619 citations

Treatment And Prevention, Antiviral Drug Development, Clinical Trials +8

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

Joseph J. Eron, Benjamin Young, David A. Cooper et al. · The Lancet · 2010 · 312 citations

Switchmrk 1, Treatment And Prevention, Human Retrovirus +10

A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals

Francesco A. Procopio, Rémi Fromentin, Deanna A. Kulpa et al. · EBioMedicine · 2015 · 262 citations · Full text

Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses

Jeffrey L. Lennox, Edwin DeJesus, Daniel S Berger et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 227 citations · Full text